Health care biotech companies by today's price change
How far the share price has moved since the previous close.
Scholar Rock Holding leads the 24 health care biotech companies ranked by today's price change, at +5.02%, ahead of Twist Bioscience (+5.01%) and Adaptive Biotechnologies (+3.26%). Figures as of 19 Nov 2026, 16:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Scholar Rock Holding+5.02%
- Median
- +0.23%
- Combined market value
- CA$1.2T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Scholar Rock HoldingSRRK · Health Care | +5.02% | CA$8.8B | CA$72.10 | 5.02% up | 26% up | ||
| 2 | Twist BioscienceTWST · Health Care | +5.01% | CA$11.9B | CA$174.76 | 5.01% up | 346% up | ||
| 3 | Adaptive BiotechnologiesADPT · Health Care | +3.26% | CA$6.8B | CA$42.03 | 3.26% up | 74% up | ||
| 4 | VaxcytePCVX · Health Care | +2.81% | CA$13.6B | CA$86.06 | 2.81% up | 23% up | ||
| 5 | CG OncologyCGON · Health Care | +2.49% | CA$10.5B | CA$117.28 | 2.49% up | 97% up | ||
| 6 | Revolution MedicinesRVMD · Health Care | +2.40% | CA$50.6B | CA$234.09 | 2.40% up | 129% up | ||
| 7 | RepligenRGEN · Health Care | +1.66% | CA$16B | CA$251.07 | 1.66% up | 12% up | ||
| 8 | ModernaMRNA · Health Care | +1.35% | CA$115.4B | CA$285.28 | 1.35% up | 780% up | ||
| 9 | Kodiak SciencesKOD · Health Care | +0.74% | CA$9.2B | CA$140.93 | 0.74% up | 399% up | ||
| 10 | argenxARGX · Health Care | +0.73% | CA$85.3B | CA$1,356.07 | 0.73% up | 2% up | ||
| 11 | CRISPR TherapeuticsCRSP · Health Care | +0.45% | CA$5.6B | CA$57.74 | 0.45% up | 18% down | ||
| 12 | Krystal BiotechKRYS · Health Care | +0.29% | CA$13.4B | CA$452.37 | 0.29% up | 54% up | ||
| 13 | QiagenQGEN · Health Care | +0.16% | CA$14.7B | CA$71.00 | 0.16% up | 9% up | ||
| 14 | Bio-TechneTECH · Health Care | -0.04% | CA$16.3B | CA$104.02 | 0.04% down | 24% up | ||
| 15 | ImmunovantIMVT · Health Care | -0.33% | CA$9.8B | CA$47.29 | 0.33% down | 46% up | ||
| 16 | AmgenAMGN · Health Care | -0.42% | CA$342B | CA$632.25 | 0.42% down | 32% up | ||
| 17 | ImmunityBioIBRX · Health Care | -0.60% | CA$10.1B | CA$9.53 | 0.60% down | 232% up | ||
| 18 | BiogenBIIB · Health Care | -0.80% | CA$52.7B | CA$356.74 | 0.80% down | 49% up | ||
| 19 | Gilead SciencesGILD · Health Care | -0.81% | CA$297.4B | CA$239.74 | 0.81% down | 35% up | ||
| 20 | BioNTechBNTX · Health Care | -1.26% | CA$29.2B | CA$117.59 | 1.26% down | 14% down | ||
| 21 | Kymera TherapeuticsKYMR · Health Care | -1.37% | CA$14.6B | CA$170.88 | 1.37% down | 87% up | ||
| 22 | Neurocrine BiosciencesNBIX · Health Care | -1.97% | CA$23.1B | CA$228.35 | 1.97% down | 17% up | ||
| 23 | Halozyme TherapeuticsHALO · Health Care | -2.46% | CA$15.2B | CA$133.65 | 2.46% down | 39% up | ||
| 24 | ExelixisEXEL · Health Care | -2.80% | CA$23.2B | CA$94.95 | 2.80% down | 63% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4303 CAD).
Questions and answers
Which health care biotech companies rank first by today's price change?
Scholar Rock Holding (+5.02%), Twist Bioscience (+5.01%) and Adaptive Biotechnologies (+3.26%) are the top three of the 24 health care biotech companies ranked by today's price change as of 19 Nov 2026, 16:50 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by today's price change.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by today's price change have a combined market value of CA$1.2T as of 19 Nov 2026, 16:50 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care biotech companies by today's price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.